These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16764352)

  • 1. No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients.
    Ristić S; Lovrecić L; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Barac-Latas V; Vejnović D; Sepcić J; Kapović M; Peterlin B
    Mult Scler; 2006 Jun; 12(3):360-2. PubMed ID: 16764352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
    Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
    Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients.
    Ristić S; Lovrecić L; Starcević-Cizmarević N; Brajenović-Milić B; Sega Jazbec S; Sepcić J; Kapović M; Peterlin B
    Eur Neurol; 2007; 57(4):203-7. PubMed ID: 17268200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients.
    Cizmarević NS; Gašparović I; Peterlin B; Sepčić J; Rudolf G; Kapović M; Lavtar P; Ristić S
    Int J Immunogenet; 2011 Oct; 38(5):419-26. PubMed ID: 21797987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
    Benešová Y; Vašků A; Stourač P; Hladíková M; Fiala A; Bednařík J
    J Neuroimmunol; 2013 Feb; 255(1-2):92-6. PubMed ID: 23186557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.
    Comabella M; Altet L; Peris F; Villoslada P; Sánchez A; Montalban X
    Mult Scler; 2004 Dec; 10(6):618-20. PubMed ID: 15584484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5Δ32 - A piece of protection in the inflammatory puzzle of multiple sclerosis susceptibility.
    Troncoso LL; Pontillo A; Oliveira EML; Finkelszteijn A; Schneider S; Chies JAB
    Hum Immunol; 2018 Aug; 79(8):621-626. PubMed ID: 29729320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients.
    Mohammadzadeh A; Pourfathollah AA; Sahraian MA; Behmanesh M; Daneshmandi S; Moeinfar Z; Heidari M
    J Neurol Sci; 2012 Jan; 312(1-2):166-9. PubMed ID: 21864851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAI and TPA gene polymorphisms in multiple sclerosis.
    Lovrecic L; Ristić S; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Sepcić J; Kapović M; Peterlin B
    Mult Scler; 2008 Mar; 14(2):243-7. PubMed ID: 17986506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis.
    Kümpfel T; Gerdes LA; Wacker T; Blaschek A; Havla J; Krumbholz M; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Mult Scler; 2012 Sep; 18(9):1229-38. PubMed ID: 22337722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene?
    Unal A; Dursun A; Emre U; Tascilar NF; Ankarali H
    J Neurol Sci; 2010 Jul; 294(1-2):38-42. PubMed ID: 20483145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
    J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.
    Matesanz F; Fedetz M; Collado-Romero M; Fernández O; Guerrero M; Delgado C; Alcina A
    J Neuroimmunol; 2001 Sep; 119(1):101-5. PubMed ID: 11525806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.
    Münch C; Meyer R; Linke P; Meyer T; Ludolph AC; Haas J; Hemmer B
    Acta Neurol Scand; 2007 Oct; 116(4):231-4. PubMed ID: 17824900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
    Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
    J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
    Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
    Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
    Gray OM; Abdeen H; McDonnell GV; Patterson CC; Graham CA; Hawkins SA
    Mult Scler; 2009 Mar; 15(3):299-303. PubMed ID: 19244395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.